NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Publish the phase I/II results? The results are dated, so it would be an odd PR move.

Then why did Dr B state at ASCO 17 they were in the process of submitting a paper?

Why would it be an odd PR move? It is expected for investigators to publish the results of trials, good or bad. And yes, even for a P1.

And I would agree that the trial almost certainly established the primary endpoint, that it is safe enough for further trials. That is endpoint singular. The secondary endpoint has never been disclosed.

The same argument circles around often.

Long A: The Direct trial showed efficacy.
Me: They have failed to publish the actual trial results
Long B: It was a P1. Why publish results about efficacy

Longs can't have it both ways. Either show results or stop asserting they have positive efficacy results.